| John F Kokesh, MD | |
|
3841 Piper St., Suite T-230, Anchorage, AK 99508 | |
| (907) 279-8800 | |
| (907) 279-8810 |
| Full Name | John F Kokesh |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 3841 Piper St., Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427090430 | NPI | - | NPPES |
| MD1038 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 4114 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Center For Ear Nose And Throat Inc | 7012901952 | 7 |
News Archive
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
Ameritas Group announced today it has added more than 22,000 access points to the Ameritas dental network, bringing the total network size to more than 130,000 access points.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
› Verified 3 days ago
| Entity Name | Alaska Center For Ear Nose And Throat Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821046152 PECOS PAC ID: 7012901952 Enrollment ID: O20040413000836 |
News Archive
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
Ameritas Group announced today it has added more than 22,000 access points to the Ameritas dental network, bringing the total network size to more than 130,000 access points.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
› Verified 3 days ago
| Entity Name | The Petersburg Medical Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1437122843 PECOS PAC ID: 5395730626 Enrollment ID: O20061104000713 |
News Archive
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
Ameritas Group announced today it has added more than 22,000 access points to the Ameritas dental network, bringing the total network size to more than 130,000 access points.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
› Verified 3 days ago
| Entity Name | Medical Network Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538414834 PECOS PAC ID: 3072618859 Enrollment ID: O20070424000329 |
News Archive
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
Ameritas Group announced today it has added more than 22,000 access points to the Ameritas dental network, bringing the total network size to more than 130,000 access points.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John F Kokesh, MD 3841 Piper St., Suite T-230, Anchorage, AK 99508 Ph: (907) 279-8800 | John F Kokesh, MD 3841 Piper St., Suite T-230, Anchorage, AK 99508 Ph: (907) 279-8800 |
News Archive
EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company's key product candidates.
Scientists at Stanford University have developed a new laser therapy that destroys cancer cells but leaves healthy ones unharmed. The new, non-invasive treatment is described in a study published in the Aug. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).
Results of a new study support the hypothesis that chronic periodontal infection increases the risk of developing preeclampsia in pregnant women.
Ameritas Group announced today it has added more than 22,000 access points to the Ameritas dental network, bringing the total network size to more than 130,000 access points.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
› Verified 3 days ago
Dr. Jamie Swartz, DO Otolaryngology Medicare: Medicare Enrolled Practice Location: 673 Mdg/sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-1035 | |
Christopher Edward Kowalski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St., Suite T-230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Dr. Mark B. Lorenz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3730 Rhone Cir Ste 203, Anchorage, AK 99508 Phone: 907-563-3515 Fax: 907-563-3541 | |
Dr. Laura Louise Shively, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508 Phone: 907-729-1400 | |
Jack Arlyn Smith, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4001 Dale St, #201, Anchorage, AK 99508 Phone: 907-561-1185 | |
Dr. James E Kallman, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper St, Suite T230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Randall Leslie Plant, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 |